Q2-26 net sales rose 25% year-over-year to $210.7 million, with gross margin improving to 39.9%. Non-GAAP net earnings more than doubled, and adjusted EBITDA margin expanded. Equity proceeds were used to pay down debt, and Q3-26 guidance anticipates continued strong sales and margins.Original docum…
Q2-26 net sales rose 25% year-over-year to $210.7 million, with gross margin improving to 39.9%. Non-GAAP net earnings more than doubled, and adjusted EBITDA margin expanded. Equity proceeds were used to pay down debt, and Q3-26 guidance anticipates continued strong sales and margins.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
